Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Chevron, D.R. Horton fall; Pfizer, Brooks Automation rise

09/20/2021 | 04:17pm EDT

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:

CBRE Group Inc., down $1.25 to $94.53.

All Storage is considering a sale and reportedly working with the commercial real estate company.

Omnicom Group Inc., down 91 cents to $71.48.

The advertising company is buying public relations and communications agency Oliver Schrott Kommunikation.

Chevron Corp., down $1.98 to $94.78.

Oil prices fell and weighed down energy companies.

Freeport-McMoRan Inc., down $1.88 to $31.17.

The copper and gold mining company's stock fell as copper prices slumped.

Brooks Automation Inc., up $8.31 to $102.45.

The maker of automation and life sciences equipment is selling its automation business for $3 billion.

Tesla Inc., down $29.32 to $730.17.

The head of the National Transportation Safety Board reportedly said the electric vehicle maker should hold off on upgrades to its driver-assistance software.

D.R. Horton Inc., down $2.72 to $88.08.

The homebuilder lowered its forecast for home closings in the fourth quarter because of supply chain issues.

Pfizer Inc., up 31 cents to $44.20.

The drug developer said its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for that age group soon.

Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

Stocks mentioned in the article
ChangeLast1st jan.
BROOKS AUTOMATION, INC. 1.12% 109.83 Delayed Quote.61.87%
CBRE GROUP, INC. 0.94% 104.9 Delayed Quote.65.69%
CHEVRON CORPORATION 0.93% 113.85 Delayed Quote.34.81%
D.R. HORTON, INC. -0.02% 88.57 Delayed Quote.28.54%
PFIZER, INC. -0.02% 43.15 Delayed Quote.17.25%
All news about PFIZER, INC.
05:58pMODERNA : U.S. administers 414.3 mln doses of COVID-19 vaccines - CDC
RE
01:09pPFIZER : Moderna says studies show COVID-19 vaccine safe, effective in children 6-11
AQ
11:31aPFIZER : Moderna says its low-dose COVID shot works for kids 6 to 11
AQ
11:28aModerna Shares Higher After Interim Data for Covid-19 Vaccine in Children
DJ
10:43aPfizer, Moderna and J&J Booster Shots Now Available at Walmart and Sam's Club Pharmacie..
AQ
09:45aANALYSIS : Capitol Hill drug pricing reform opponents among the biggest beneficiaries of p..
RE
07:39aUNIVERSITY OF BIRMINGHAM : A third of leukaemia patients do not generate any antibody resp..
AQ
05:51aFORMER EMPLOYEE : Pfizer is like an 'abusive, rich husband' with frequent virtue signallin..
AQ
05:10aPFIZER : Prime Minister issues vaccine call to arms ahead of winter
AQ
04:04aPFIZER : United States Donates 1.4 Million More COVID-19 Pfizer Vaccines to Egypt
AQ
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 557 M - -
Net income 2021 18 627 M - -
Net Debt 2021 29 307 M - -
P/E ratio 2021 12,7x
Yield 2021 3,66%
Capitalization 242 B 242 B -
EV / Sales 2021 3,33x
EV / Sales 2022 3,79x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 43,15 $
Average target price 45,72 $
Spread / Average Target 5,96%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.17.25%241 985
JOHNSON & JOHNSON4.26%430 990
ROCHE HOLDING AG15.15%337 974
NOVO NORDISK A/S58.77%242 392
ELI LILLY AND COMPANY45.14%220 979
MERCK & CO., INC.-0.79%205 421